Skip to main content
Clinical Trials/NCT04325412
NCT04325412
Unknown
N/A

Cardiac complicAtions in Patients With SARS Corona vIrus 2 regisTrY

UMC Utrecht1 site in 1 country1,000 target enrollmentMarch 23, 2020

Overview

Phase
N/A
Intervention
Not specified
Conditions
COVID-19; Cardiovascular Diseases
Sponsor
UMC Utrecht
Enrollment
1000
Locations
1
Primary Endpoint
The incidence of cardiovascular complications in patients with COVID-19
Last Updated
5 years ago

Overview

Brief Summary

CAPACITY (www.capacity-covid.eu) is a registry of patients with COVID-19 across Europe and has been established to answer questions on the role of cardiovascular disease in this pandemic. It is an extension of the Case Record Form (CRF) that was released by the ISARIC (International Severe Acute Respiratory and Emerging Infection Consortium) and WHO (World Health Organisation) in response to the emerging outbreak of COVID-19.

Detailed Description

The aim of CAPACITY is to collect data regarding the cardiovascular history, diagnostic information and occurrence of cardiovascular complications in COVID-19 patients. By collecting this information in a standardized manner, CAPACITY can aid in providing more insight in (1) the incidence of cardiovascular complications in patients with COVID-19, and (2) the vulnerability and clinical course of COVID-19 in patients with an underlying cardiovascular disease. The CAPACITY extension to the ISARIC-WHO CRF consists of additional data collection instruments for: * cardiac history and cardiovascular risk factors * prior use of cardiac medication or NSAIDs * electrocardiography (ECG) * echocardiography * cardiac MRI * invasive cardiac procedures * cardiac complications * cardiac biomarkers * cardiac outcome during admission

Registry
clinicaltrials.gov
Start Date
March 23, 2020
End Date
June 23, 2021
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Prof. Dr. F.W. Asselbergs

Prof. Dr. F.W. Asselbergs

UMC Utrecht

Eligibility Criteria

Inclusion Criteria

  • Highly suspected/confirmed infection with SARS-CoV-2

Exclusion Criteria

  • Patients that opt-out

Outcomes

Primary Outcomes

The incidence of cardiovascular complications in patients with COVID-19

Time Frame: 30 days

Study Sites (1)

Loading locations...

Similar Trials